NuCana PLC Sponsored ADR (NCNA) vs Pulmatrix, Inc. (PULM)

NuCana PLC Sponsored ADR and Pulmatrix, Inc. are both Biotechnology companies. NuCana PLC Sponsored ADR and Pulmatrix, Inc. are of similar size ($6.1M and $5.7M). Across the 10 metrics below, NuCana PLC Sponsored ADR leads on 5 and Pulmatrix, Inc. on 5.

Valuation

Metric NCNA PULM Biotechnology median
P/E n/m n/m 7.88
P/S n/m 0.76 11.47
P/B 0.00 3.74 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.45 n/m 0.74
EV/Sales n/m 1.50 10.73
Earnings yield (175,037.66%) (67.48%) (28.84%)
Free cash flow yield (131,687.13%) (72.37%) (23.03%)

Profitability

Metric NCNA PULM Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (68.70%) (111.99%) (57.72%)
Return on assets (45.24%) (85.74%) (49.22%)
Return on invested capital (1,130.23%) 0.00% 0.00%

Growth

Metric NCNA PULM Biotechnology median
Revenue growth (TTM) — 6.96% 5.64%
EPS growth (last fiscal year) 98.96% 46.18% —
Revenue growth, 5-year CAGR — (0.26%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NCNA PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.73 4.70 4.73
Net debt to EBITDA 1.23 0.79 0.96

Dividend

Metric NCNA PULM Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NCNA PULM Biotechnology median
Market cap 5.69m 6.10m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack